691900-70-6 Usage
Description
1-N-BOC-6-METHOXY-3-METHYL-1H-INDAZOLE is a chemical compound that belongs to the indazole class of chemicals. It is a derivative of indazole and is characterized by a BOC (tert-butoxycarbonyl) protecting group on the nitrogen atom, a methoxy group at the 6-position, and a methyl group at the 3-position of the indazole ring.
Uses
Used in Organic Synthesis:
1-N-BOC-6-METHOXY-3-METHYL-1H-INDAZOLE is used as a building block for the preparation of various biologically active molecules and pharmaceutical compounds. Its unique structure and functional groups make it a valuable component in the synthesis of complex organic molecules.
Used in Medicinal Chemistry:
1-N-BOC-6-METHOXY-3-METHYL-1H-INDAZOLE is used as a key intermediate in the development of new pharmaceutical compounds. Its presence in the molecular structure can influence the biological activity and pharmacological properties of the final product.
Used in Drug Discovery Research:
1-N-BOC-6-METHOXY-3-METHYL-1H-INDAZOLE is used as a starting material in drug discovery research to explore its potential as a therapeutic agent or to modify its structure to create new drug candidates with improved efficacy and selectivity.
Check Digit Verification of cas no
The CAS Registry Mumber 691900-70-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,9,1,9,0 and 0 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 691900-70:
(8*6)+(7*9)+(6*1)+(5*9)+(4*0)+(3*0)+(2*7)+(1*0)=176
176 % 10 = 6
So 691900-70-6 is a valid CAS Registry Number.
691900-70-6Relevant articles and documents
Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
-
Page/Page column 19, (2008/06/13)
The present invention relates to compounds of formula (I): in which R1, R2, R3, X, Y and A are as defined in the specification. The compounds are modulators of the estrogen receptors.
Ophthalmic compositions for treating ocular hypertension
-
, (2008/06/13)
This invention relates to potent potassium channel blocker compounds of Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relate
